Engineers Gate Manager’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$678K Buy
5,392
+2,273
+73% +$286K 0.01% 1330
2025
Q1
$345K Sell
3,119
-15,847
-84% -$1.75M 0.01% 1632
2024
Q4
$2.59M Sell
18,966
-57,656
-75% -$7.87M 0.05% 522
2024
Q3
$8.83M Buy
76,622
+41,978
+121% +$4.84M 0.17% 151
2024
Q2
$4.77M Buy
34,644
+17,542
+103% +$2.42M 0.11% 274
2024
Q1
$2.36M Buy
17,102
+7,487
+78% +$1.03M 0.06% 419
2023
Q4
$1.27M Sell
9,615
-13,205
-58% -$1.74M 0.04% 666
2023
Q3
$2.57M Buy
22,820
+5,832
+34% +$656K 0.09% 291
2023
Q2
$1.6M Sell
16,988
-734
-4% -$69.2K 0.06% 444
2023
Q1
$1.79M Buy
17,722
+13,625
+333% +$1.38M 0.07% 343
2022
Q4
$489K Buy
+4,097
New +$489K 0.03% 907
2022
Q3
Sell
-5,262
Closed -$513K 1919
2022
Q2
$513K Buy
5,262
+1,539
+41% +$150K 0.02% 1096
2022
Q1
$349K Buy
3,723
+976
+36% +$91.5K 0.01% 1291
2021
Q4
$234K Sell
2,747
-3,909
-59% -$333K 0.01% 1555
2021
Q3
$638K Sell
6,656
-5,149
-44% -$494K 0.04% 738
2021
Q2
$1.15M Buy
+11,805
New +$1.15M 0.07% 372
2020
Q4
Sell
-12,618
Closed -$1.21M 1881
2020
Q3
$1.21M Buy
12,618
+8,983
+247% +$864K 0.06% 518
2020
Q2
$443K Buy
3,635
+929
+34% +$113K 0.02% 1007
2020
Q1
$234K Sell
2,706
-21,399
-89% -$1.85M 0.02% 1177
2019
Q4
$2.59M Buy
24,105
+18,635
+341% +$2M 0.11% 260
2019
Q3
$493K Buy
+5,470
New +$493K 0.03% 789
2019
Q2
Sell
-2,400
Closed -$211K 1302
2019
Q1
$211K Buy
+2,400
New +$211K 0.01% 819